Table 2.
Compd. | EGFR Inhibition IC50 ± SEM (nM) |
BRAFV600E Inhibition IC50 ± SEM (nM) |
---|---|---|
21 | 72 ± 5 | 73 ± 6 |
24 | 73 ± 5 | 77 ± 6 |
28 | 70 ± 5 | 69 ± 6 |
29 | 75 ± 5 | 80 ± 7 |
30 | 68 ± 4 | 65 ± 5 |
Erlotinib | 80 ± 5 | ± 5 |
Compd. | EGFR Inhibition IC50 ± SEM (nM) |
BRAFV600E Inhibition IC50 ± SEM (nM) |
---|---|---|
21 | 72 ± 5 | 73 ± 6 |
24 | 73 ± 5 | 77 ± 6 |
28 | 70 ± 5 | 69 ± 6 |
29 | 75 ± 5 | 80 ± 7 |
30 | 68 ± 4 | 65 ± 5 |
Erlotinib | 80 ± 5 | ± 5 |